ABUS vs ATO · P/E 5.4, rev $6.2M vs P/E 22, rev $4.70B
Arbutus Biopharma Corp (ABUS) versus Atmos Energy Corporation (ATO) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Atmos Energy Corporation (ATO) is a utilities - regulated gas company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ATO revenue for 2025-09-30 was $4.70B. Net income was $1.20B. Revenue was up 12.9% from 2024-09-30 to 2025-09-30. ATO currently screens at market cap $24.52B and trailing P/E 21.6.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ATO currently screens at market cap $24.52B and trailing P/E 21.6.
Not investment advice. Open the ABUS and ATO stock pages for the full models.
Not investment advice.